Abstract:Objective: To investigate the expression of serum glial fibrillary acidic protein (GFAP) and insulin-like growth factor-1 (IGF-1) in brain glioma and its correlation with clinicopathological prognosis.Methods: A retrospective analysis was performed on 74 patients with glioma admitted to our hospital from April 2014 to May 2015. These patients were selected as the observation group, and 67 healthy patients in our hospital were selected as the control group. All patients in the observation group were treated with surgery combined with chemoradiotherapy. The levels of GFAP and IGF-1 in the control group were compared on the day of physical examination and in the observation group before and after 1w as well as after chemoradiotherapy. According to the survival time of glioma patients, the patients were divided into 27 patients with good prognosis and 47 patients with poor prognosis. GFAP and IGF-1 levels were compared between the two groups. Patients were divided into a complete remission group, a partial remission group, a stable group and a progressive group according to the efficacy evaluation criteria of solid tumours. GFAP and IGF-1 levels were compared in each group. An ROC curve was drawn to analyse the diagnostic value of GFAP and IGF-1 in the prognosis of glioma.Results: In comparison with the control group, GFAP and IGF-1 levels were significantly higher in the observation group at all time periods (P<0.05). Compared with the preoperative level, the GFAP and IGF-1 levels in the observation group were significantly decreased 1w after surgery and after chemoradiotherapy (P<0.05). Compared with 1w after surgery, GFAP and IGF-1 levels in the observation group after radiotherapy and chemotherapy were significantly reduced (P<0.05). Compared with the group having a good prognosis, GFAP and IGF-1 in the group with poor prognosis were significantly increased (P<0.05). Compared with the complete remission group, the GFAP and IGF-1 levels of patients in the partial remission group, stable group and progressive group were significantly increased. GFAP and IGF-1 levels were significantly higher than those in the stable group and the progressive group (P<0.05). The area under the GFAP and IGF-1 curves were 0.842 and 0.955, the specificity was 87.70% and 92.30%, and the sensitivity was 82.50% and 90.00%, respectively.Conclusion: The expression levels of GFAP and IGF-1 in the serum of glioma patients were significantly increased, and both can be used as reference indexes for evaluating the prognosis of glioma patients, which is conducive to improving diagnostic efficiency and accuracy.

The expression of insulin-like growth factor-I receptor in human glioma and its significance

Polymeric Immunoglobulin Receptor Expression is Predictive of Poor Prognosis in Glioma Patients.

Polymeric Immunoglobulin Receptor Expression Is Predictive Of Poor Prognosis In Glioma Patients

The Expression of CD44s and Mib-1 in Astrocytomas and Their Clinical Significance

Expression and significance of vascuIar endothelial growth factor and VIII-R Ag in human brain glioma

Expression and significance of vascuIar endothelial growth factor and Ⅷ-R Ag in human brain glioma

The Expression and Significance of IGF-I,Ki-67 and Bcl-2 in Human Glioma.

Expression and clinical significance of serum IGF-I and TSGF in human glioma

The significance of determination of insulin-like growth factor-1、insulin-like growth factor binding protein-3 in glioma patients

Expression of Insulin-Like Growth Factor-Ⅰ Receptor in Human Medulloblastomas and Its Signifgicance

Relationship of Cx43 and IGF-Ⅰ with Malignancy Degree of Human Glioma

Expression Of Serum Gfap And Igf-1 In Glioma And Its Relationship With Clinicopathological Prognosis

IGF-I and IGFPB-3 in Different Types of Brain Tumors

The Signiifcance of Determination of Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 in Meningioma Patients

Clinical Significance of Iroquois Homeobox Gene - IRX1 in Human Glioma.

Clinical Significance of Insulin-like Growth Factor Binding Protein-2 in Serum of Patients with Glioma and Meningiomas

Expression of Fibornectin and Β1 Integrin Receptor in Human Brain Glioma

Study of MMP-2,MMP-9,TIMP-1 and TIMP-2 expression in human glioma

The Expression of HIF-1α and Its Relationship to Apoptosis and Prognostic Significance in Human Glioma

Expression of Interleukin 6,signal Transducer and Activator of Transcription 3 and Vascular Endothelial Growth Factor in Human Glioma and Their Relationship

Expressions and Significances of Endostatin and VEGF in Human Glioma